logo

Foamix Pharmaceuticals Ltd. (FOMX)



Trade FOMX now with
  Date
  Headline
10/12/2018 8:04:44 AM Foamix To Present Clinical Data From Study FX2017-22
10/1/2018 8:19:19 AM Foamix Announces Addl Positive Topline Results From Third Phase 3 Trial Of FMX101 Topical Minocycline Foam
6/27/2018 8:07:45 AM Foamix Doses Last Patient In Phase 3 Rosacea Studies For Minocycline Foam FMX103; Expects Top-line Results Early Q4'18
2/28/2018 8:09:46 AM Foamix 2017 Net Loss $65.7 Mln Or $1.76 Per Share
  
 
>